Home > Press > Arrowhead Pharmaceuticals Announces Closing of Agreement with TakedaAbstract:Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the collaboration and license agreement between Arrowhead and Takeda Pharmaceutical Company Limited announced on October 8, 2020, has now closed. Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda Pasadena. CA |...